why choose us

First received: November 07, 2023

Clinical Trial: KET-RO Plus RO DBT for Treatment Resistant Depression

Study Status: Completed

Recruit Status: RECRUITING

Condition: Treatment Resistant Depression

Study Type: INTERVENTIONAL


Official Title: Medication-assisted Psychotherapy: Using Ketamine-enhanced Radically Open Dialectical Behavior Therapy (RO DBT) to Target Neural and Behavioral Mechanisms of Action in Emerging Adults With Moderate to

Brief Summary: This pilot study will assess the safety and feasibility of intravenous (IV) ketamine combined with RO DBT in young adults with Treatment-Resistant Depression (TRD).In addition, this study will develop and utilize innovative methodological approaches to demonstrate the feasibility of precision medicine with this type of therapy.

Read more